Tech Company Financing Transactions
Sonire Therapeutics Funding Round
On 6/17/2026, Sonire Therapeutics announced $13 million in funding from private investors.
Transaction Overview
Company Name
Announced On
6/17/2026
Transaction Type
Debt
Amount
$13,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The funding will support manufacturing scale-up, regulatory approval activities in Japan, expansion into additional clinical indications, and acceleration of the company's ongoing U.S. clinical development efforts.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
214 Homer Ave
Palo Alto, CA 94301
USA
Palo Alto, CA 94301
USA
Phone
Undisclosed
Website
Email Address
Overview
SONIRE Therapeutics Inc. (SONIRE) is developing a next-generation high-intensity focused ultrasound (HIFU) treatment system that uses acoustic engineering (ultrasound) technology created through cutting-edge research conducted by academia.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tohru Satoh
Chief Operating Officer
Jun Okamoto
Browse more venture capital transactions:
Prev: 6/17/2026: Triveni Bio venture capital transaction
Next: 6/17/2026: Copper by NEXT Financial venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs